Tamm-Horsfall protein is a critical renal defense factor protecting against calcium oxalate crystal formation  by Mo, Lan et al.
Kidney International, Vol. 66 (2004), pp. 1159–1166
Tamm-Horsfall protein is a critical renal defense factor
protecting against calcium oxalate crystal formation
LAN MO, HONG-YING HUANG, XIN-HUA ZHU, ELLEN SHAPIRO, DAVID L. HASTY, and XUE-RU WU
Department of Urology, Kaplan Comprehensive Cancer Center, New York University School of Medicine, New York, New York;
Department of Microbiology, Kaplan Comprehensive Cancer Center, New York University School of Medicine, New York, New
York; Veterans Affairs Medical Center, New York, New York; Department of Anatomy and Neurobiology, University of Tennessee,
Memphis, Tennessee; and Veterans Affairs Medical Center, Memphis, Tennessee
Tamm-Horsfall protein is a critical renal defense factor protect-
ing against calcium oxalate crystal formation.
Background. The tubular fluid of the mammalian kidney is of-
ten supersaturated with mineral salts, but crystallization rarely
occurs under normal conditions. The unique ability of the kid-
ney to avoid harmful crystal formation has long been attributed
to the inhibitory activity of the urinary macromolecules, al-
though few in vivo studies have been carried out to examine
this hypothesis. Here we examined the role of Tamm-Horsfall
protein (THP), the principal urinary protein, in urinary defense
against renal calcium crystal formation, using a THP knockout
model that we recently developed.
Methods. Wild-type and THP knockout mice were examined
for the spontaneous formation of renal calcium crystals using
von Kossa staining. The susceptibility of these mice to experi-
mentally induced renal crystal formation was evaluated by ad-
ministering mice with ethylene glycol, a precursor of oxalate,
and vitamin D3, which increases calcium absorption. Renal cal-
cium crystals were visualized by von Kossa stain, dark field mi-
croscopy with polarized light and scanning electron microscopy.
Results. Inactivating the THP gene in mouse embryonic stem
cells results in spontaneous formation of calcium crystals in
adult kidneys. Excessive intake of calcium and oxalate, pre-
cursors of the most common type of human renal stones, dra-
matically increases both the frequency and the severity of renal
calcium crystal formation in THP-deficient, but not in wild-type
mice. Under high calcium/oxalate conditions, the absence of
THP triggers a marked, adaptive induction in renal epithelial
cells of osteopontin (OPN), a potent inhibitor of bone miner-
alization and vascular calcification. Thus, OPN may serve as an
inducible inhibitor of calcium crystallization, whereas THP can
serve as a constitutive and apparently more effective inhibitor.
Conclusion. These results provide the first in vivo evidence
that THP is a critical urinary defense factor and suggest that its
deficiency could be an important contributing factor in human
nephrolithiasis, a condition afflicting tens of millions of people
in the world annually.
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Renal stone disease or nephrolithiasis is an exceedingly
common clinical condition in the industrialized world. Up
to 15% of white males and 6% of all females will have
at least one renal stone during their lifetime, and half
of these individuals will experience recurrence [1, 2]. In
the United States, the disease afflicts more than 1 million
people annually and accounts for nearly 10 of every 1000
hospital admissions. The incidence of this disease appears
to be on the rise during recent decades, although the exact
cause for this increase is unknown. Among the various
types of renal stones, those composed of calcium oxalate
are by far the most prevalent, accounting for 75% of all
stones [3].
Renal stone formation is believed to be contingent
upon two critical factors. The first is the state of super-
saturation in which there is an overabundance of stone-
forming ions, exceeding the metastable limit [1, 2, 4]. If
unopposed, supersaturation can lead to crystallization,
triggering a series of pathophysiologic events that include
nucleation, crystal aggregation, growth, and attachment
to epithelia [5, 6]. The second critical factor is the pres-
ence of urinary macromolecules that can exert inhibitory
effects on various phases of renal crystal formation [7, 8].
It has been suggested that the level and functional status
of specific urinary macromolecules is an important con-
tributing factor in individual susceptibility to renal stones
[4, 7]. Two notable candidates for inhibition of crystal for-
mation are osteopontin (OPN) and Tamm-Horsfall pro-
tein (THP), also known as uromodulin.
OPN is an acidic phosphorylated glycoprotein initially
isolated from bone matrix. It is believed to play a role
in modulating mineralization of normal bone by enhanc-
ing osteoclast activity and halting hydroxyapatite crystal
growth [9]. Targeted deletion of the murine OPN gene
did not result in a mineralization defect, but it enhanced
vascular calcification in mice also deficient for the ex-
tracellular matrix Gla protein, suggesting that these two
proteins can act in concert to inhibit ectopic calcification
[10]. In addition to being expressed in bone, OPN is also
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expressed by normal renal epithelial cells, particularly
cells of the ascending limb of Henle’s loop and the distal
convoluted tubules, and it is secreted into the urine at
about 4 mg per day [11, 12]. Evidence supporting a role
for OPN as an inhibitor of renal stone formation includes
the observations that: OPN is a major component of hu-
man renal stones [13]; purified OPN inhibits the nucle-
ation, growth, and aggregation of calcium oxalate crystals
in vitro and reduces the binding of the crystals to renal
epithelial cells in vitro [8]; OPN is up-regulated in renal
tubules upon overexposure to calcium oxalate in experi-
mental models [14]; and OPN knockout mice develop ex-
perimentally induced renal calcium oxalate crystals after
exposure to high levels of oxalate, but not under normal
conditions [15, 16].
THP is expressed by the same kidney epithelial cells
that express OPN, but unlike OPN, THP is kidney-
specific [17, 18]. THP is initially synthesized as a glycosyl-
phosphatidylinositol (GPI)–anchored membrane protein
and released into the urine upon the cleavage of the
anchorage by phospholipases or proteases [19–21]. Re-
leased THP is the most abundant protein found in urine
of all placental animals, amounting to 100 mg daily in hu-
mans. Because of its urinary abundance and its consistent
presence in human renal stones, it has been proposed that
THP may play a role in regulating stone formation. How-
ever, in vivo evidence is lacking and controversy persists
as to whether THP is a promoter, inhibitor, or innocent
bystander during stone formation [1, 22, 23]. In this study,
we investigated the in vivo role of THP as a host defense
factor against renal crystal formation using THP knock-
out mice that we recently generated [24].
METHODS
THP knockout and wild-type mice
Inactivation of murine THP gene was achieved by the
deletion of a THP gene fragment containing the proxi-
mal promoter as well as exons 1 to 4, through homolo-
gous recombination in embryonic stem cells [24]. Mice
homozygous for the mutated THP allele lacked renal
expression of THP mRNA by both Northern blotting
and reverse transcription-polymerase chain reaction (RT-
PCR) analyses, and did not synthesize any THP protein
as demonstrated by Western blotting of the total kidney
and urinary proteins and by immunohistochemical stain-
ing. Both THP knockout and wild-type control mice were
bred continuously in a 129/SvEv genetic background. An-
imals in the sixth and seventh generations were used in the
current study. The genotype of the experimental animals
was confirmed by Southern blotting of EcoRI-digested
tail DNA using a targeting event–specific probe. All ani-
mal studies were conducted in accordance with National
Institutes of Health (NIH) guidelines for the use and care
of laboratory animals and under an active protocol ap-
proved by the investigators’ institute’s animal care and
use committee.
Detection of renal calcium crystals
Spontaneous formation of renal calcium crystals in
THP knockout mice (2 to 4 months old) was assessed
by von Kossa histochemical staining, which specifically
reacts with calcium deposits in the tissue [25]. Briefly,
4 l thick sagittal sections of paraffin-embedded mouse
kidneys were deparaffinized, hydrated, and exposed to
2% silver nitrate under bright light for 60 minutes. After
washing in 5% sodium thiosulfate for 5 minutes, the sec-
tions were counterstained with neutral red and examined
under a light microscope. Alternatively, the paraffin sec-
tions were stained with hemotoxylin and eosin, followed
by microscopic visualization of the birefringent crystals
under dark field illumination with polarized light (Axio-
plan II microscope) (Zeiss, Oberkochen, Germany).
Experimental induction of renal calcium
crystal formation
Adult male THP knockout and wild-type mice (both 2
to 4 months of age) were administered 1% ethylene glycol
(Sigma Chemical Co., St. Louis, MO, USA) and 4 IU/mL
Vitamin D3 (Twin Laboratories, Inc., Hauppange, NY,
USA) in the drinking water continuously for 1 month.
Treated mice were then sacrificed and their kidneys pro-
cessed for either histochemical or biochemical analyses.
Scanning electron microscopy and x-ray
elemental analysis of renal crystals
Five 10 lm thick paraffin sections of kidney were
floated on a warm water bath and mounted on carbon
planchets. Sections were deparaffinized while they were
on the planchet. Uncoated specimens were analyzed
by scanning electron microscopy with a Philips XL30
ESEM microscope (FEI Philips, Boston, MA, USA) in
the backscatter electron mode. Dense materials were eas-
ily detected in the backscatter electron (BSE) mode be-
cause they were much brighter than surrounding tissue.
Elemental spectra of crystals were determined by en-
ergy dispersive x-ray analysis (Edax Corp., Mahwah, NJ,
USA).
RNA and protein analyses
For the assessment of renal expression of OPN and
THP under various normal and experimental conditions,
total RNA was isolated using an RNA extraction kit
(Promega, Madison, WI, USA). Fifteen micrograms of
the total RNA were resolved by formaldehyde-agarose
gel, transferred onto a nylon membrane, and hybridized
with cDNA probes specific for mouse OPN and mouse
THP cDNA probe. After autoradiography, the nylon
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membrane was heat-stripped and rehybridized with a b-
actin probe.
For the assessment of protein expression, fresh mouse
kidney tissues were directly homogenized in sodium do-
decyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) loading buffer. Solubilized total kidney proteins
were electrophoresed, transferred onto an immobilon-
polyvinylidine difluoride (PVDF) membrane and re-
acted with an anti-OPN antibody (Assay Designs, Inc.,
Ann Arbor, MI, USA). The reaction was visualized by
an enhanced chemiluminescence (ECL) detection sys-
tem (Amersham, Piscataway, NJ, USA). Immunoreac-
tion to mitogen-activated protein kinase (MAPK) (New
England Biolabs, Inc., Beverly, MA, USA) was used as a
loading control.
Immunohistochemistry
Freshly dissected kidney tissues were fixed in 10%
buffered formalin and processed routinely for paraffin
embedding. Four micron tissue sections were microwaved
in a citrate buffer (pH 6.0) for 15 minutes for anti-
gen retrieval and were then stained with the anti-OPN
antibodies.
Statistical analysis
Differences in spontaneous and experimentally in-
duced renal crystal formation were statistically analyzed
using the chi-square (v 2) test. P values < 0.05 were con-
sidered significant.
RESULTS
Spontaneous formation of renal calcium crystals
in THP knockout mice
Our laboratory recently generated transgenic mice
lacking the THP gene. The mice were completely lacking
the THP message and THP protein [24]. The availability
of these transgenic mice provided the first opportunity
for us to examine the hypothesis that THP plays a role in
inhibiting renal calcium crystal formation in vivo. When
we stained kidney sections of the THP knockouts using
von Kossa stain, which specifically reacts with calcium
deposits, we observed dark, dense intratubular crystal
aggregates (Fig. 1B to D). These crystals were located
primarily in the collecting ducts in deep medulla and re-
nal papillae, with some of the crystals clearly attached to
the luminal surfaces of the tubular epithelial cells (Fig. 1B,
inset, and D). Four out of 25 THP knockout mice exam-
ined, but none out of 25 wild-type littermates, harbored
significant numbers of renal crystals (P < 0.05) (Table 1)
strongly suggesting that renal calcium crystal formation
was a direct result of THP deficiency.
THP deficiency dramatically increased susceptibility of
mice to experimentally induced renal crystal formation
To test whether the absence of THP also reduces the
ability of the urinary system to respond to mineral over-
load, we fed THP knockout and wild-type littermates in
the drinking water with ethylene glycol, an oxalate pre-
cursor, and vitamin D3, which enhances calcium absorp-
tion and produces a hypercalciuric condition. Wild-type
mice remained completely crystal-free under high cal-
cium/high oxalate conditions (Fig. 2A and E) (Table 1),
but THP knockout mice developed large numbers of re-
nal crystals that were both reactive with silver nitrate of
the von Kossa solution (Fig. 2B to D) and were distinc-
tively light-reflective upon dark field microscopy with po-
larized light illumination (Fig. 2F). The outer medulla of
the kidney, a region in which ascending limbs of Henle’s
loop are concentrated and where THP is normally ex-
pressed (Fig. 2B, boxed area), harbored the greatest num-
ber of crystals. In addition, crystals were found in the
collecting ducts of the deep medulla and renal papillae.
Intratubular crystals were also seen in tissue sections ana-
lyzed by scanning electron microscopy in the backscatter
electron mode (Fig. 3A and B). Elemental analysis deter-
mined by energy dispersive x-ray analysis (Edax) showed
that the crystals consisted primarily of calcium, oxygen,
and carbon, with little to no phosphate (Fig. 3C and 3D),
strongly suggesting that the crystals were of calcium ox-
alate in nature. Overall, 13 of 17 knockout mice that had
been pretreated with ethylene glycol and vitamin D3 de-
veloped renal calcium crystals. In contrast, none of the 16
similarly treated wild-type littermates developed crystals
(P < 0.001) (Table 1). These results indicate that THP is a
critical inhibitor of calcium crystal formation and that its
deficiency predisposes the urinary system to developing
calcium crystals.
Compensatory induction of OPN in THP-deficient mice
Because both OPN and THP are expressed by the as-
cending limb of Henle’s loop and both exhibit calcium
crystal inhibition activity, we wished to know whether
the lack of THP would provoke an adaptive increase of
OPN. Exposure of wild-type mice to calcium and oxalate
induced the expression of OPN RNA and protein over
baseline levels, albeit to a moderate degree (Fig. 4). In the
absence of a calcium/oxalate overload, THP deficiency
did not induce OPN expression over baseline levels
(Fig. 4A), but calcium/oxalate treatment dramatically in-
duced OPN expression in THP knockout mice (Fig. 4).
Virtually all renal tubules, including those normally ex-
pressing no OPN (Fig. 5A to C), expressed large amounts
of OPN (Fig. 5D to F). Even nontubular structures,
such as Bowman’s capsules, were seen to express OPN
(Fig. 5D, inset). Induction of OPN was also seen in re-
nal papillary epithelium (Fig. 5F), which only expresses
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Fig. 1. Formation of spontaneous calcium crystals in murine kidneys
of Tamm-Horsfall protein (THP) absent mice. Four micron paraffin
sections from kidneys of wild-type (A) and THP knockout mice (B to
D) were subjected to the von Kossa stain, which specifically detects
calcium deposits, and were counterstained by neutral red. There were
no reactions with the von Kossa stain in kidneys of wild-type mice. In
the kidneys of knockout mice, intensely stained, dark-colored calcium
crystals (arrows) were detected within the lumen (inset) of the kidney
tubules in the renal papilla (B) and deep medulla (C and D) [magnifi-
cations are 50× (A and B); 150× (C and D); 200 × (inset)].
small amounts of OPN under normal conditions (Fig. 5C).
The fact that there was a significantly greater induc-
tion of OPN, upon calcium/oxalate overload, in THP-
deficient mice than in wild-type mice further supports
the role of OPN as an inducible crystal inhibitor [16], and
suggests that under normal conditions THP and OPN
act synergistically in preventing urinary stone formation.
It should be pointed out, however, that in the absence
of THP, OPN induction is insufficient to suppress re-
nal crystal formation. In contrast to OPN, THP remains
unchanged during calcium/oxalate overload in wild-type
mice (Fig. 4A), suggesting that THP, which is produced in
25-fold greater amounts than OPN, acts as a constitutive
inhibitor.
DISCUSSION
A central functional requirement in the maintenance of
renal homeostasis is dealing effectively with the supersat-
uration of urine by mineral salts. Clearly a powerful set of
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Fig. 2. Experimentally induced renal calcium crystal formation. Wild-
type and Tamm-Horsfall protein (THP) knockout mice were fed 1%
ethylene glycol and 4 IU/mL Vitamin D3 in the drinking water for 1
month. The kidney sections were stained either with von Kossa stain
and viewed by light microscopy (A to D) or they were stained with
hematoxylin and eosin (E to G) and viewed under dark field with po-
larized light illumination (E and F) or by light microcopy (G). Note
that the THP knockout mice (B to D, F and G) developed numerous
renal stones that were distinctively reactive with von Kossa stain (B,
boxed area, C and D, arrowheads) and that exhibited strong birefrin-
gence in dark field (F, arrowheads). Wild-type mice were completely
unaffected (A, boxed area, and E). The induced calcium crystals are
concentrated at the outer medullary zone where THP is normally syn-
thesized (B, boxed area). (F and G) The same sections viewed with dark
field or bright field microscopy [magnifications are 50× (A and B); 400×
(C to G)].
Table 1. Renal calcium crystal formation in wild-type and
Tamm-Horsfall protein (THP)–deficient mice
Without Ca2+ overload With Ca2+ overload
Wild-type Knockout Wild-type Knockout
0/25 (0%) 4/25 (16%) 0/16 (0%) 13/17 (76%)
P < 0.05 P < 0.001
defense mechanisms is required to keep the urinary tract
free of harmful stones, but these mechanisms have been
only partially defined to date. By inactivating the murine
THP gene, we have provided the first in vivo evidence
that THP deficiency can result in renal calcium crystal
formation. These results, in conjunction with our recent
finding that THP knockout mice are prone to urinary
tract infections by type 1 fimbriated Escherichia coli [24],
indicate that THP, a kidney-specific glycoprotein, serves
as a critical first line of defense protecting against urinary
tract colonization by bacterial pathogens and formation
of renal stones. The results also suggest that a deficiency
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Fig. 3. Scanning electron microscopic and x-ray elemental analyses
of experimentally induced renal crystals. (A) Scanning electron mi-
croscopy showing a 25 lm × 25 lm intraluminal crystal aggregate com-
posed primarily of calcium (Ca), carbon (C) and oxygen (O) with very
little phosphate (P). (C) This profile strongly suggests that the crystals
are of calcium oxalate type. (B) An independent renal section show-
ing several smaller crystal aggregates that contained similar chemical
components (D).
of this major urinary protein may predispose humans to
urinary stone diseases and urinary tract infections.
Our results also provide experimental evidence sug-
gesting that, under some circumstances, THP and OPN
can function together to keep renal stones from forming
and are not merely redundant systems. OPN-deficient
mice, which presumably expressed normal amounts of
THP, did not develop renal calcium crystals unless sub-
jected to oxalate overload [15, 16]. Thus, under normal
conditions, THP is apparently a sufficient inhibitor. In
contrast, significant numbers of THP-deficient mice de-
veloped renal calcium crystals even when drinking wa-
ter. Increased calcium/oxalate uptake by wild-type mice,
which did not develop any renal calcium crystals, only
elicited a slight increase of OPN, suggesting that consti-
tutively expressed THP and slightly induced OPN can
sufficiently counter the adverse effects of mineral over-
load. In striking contrast, increased calcium/oxalate up-
take by THP-deficient mice led to dramatically increased
expression of OPN, even stimulating OPN production by
renal cell types heretofore not known to produce this gly-
coprotein. However, this compensatory increase was not
sufficient to keep calcium crystals from forming. While
our data suggest that THP is the more potent of these
two inhibitors, it is also not sufficient to keep calcium
crystals from forming when animals are exposed to in-
creased levels of oxalate, as occurring in OPN-deficient
+/+ +/+ +/+ +/+ +/+ −/− −/− −/− −/− −/− −/−
−
THP
EG/D3 − + + + − − − + + +
1 2 3 4 5 6 7 8 9 10 11
A
OPN
THP
Actin
+/+ +/+ −/− −/− −/− −/− −/−
1 2 3 4 5 6 7
−
THP
EG/D3 + − + + + +
B
OPN
MAPK
Fig. 4. Induction of osteopontin (OPN) in Tamm-Horsfall (THP)
knockout mice. Wild-type and THP knockout mice were fed with regu-
lar drinking water or that supplemented with ethylene glycol (EG) and
vitamin D3 (D3). (A) Total RNA was extracted from the whole kidneys,
electrophoresed, transferred to a nylon membrane, and hybridized with
a mouse OPN cDNA probe. Following the striping of the probe, the
same membrane was hybridized with a mouse THP probe followed by
a b-actin probe. Note that EG/D3 treatment led to a moderate induc-
tion of OPN in wild-type mice (lanes 3 to 5) and a strong induction of
OPN in THP knockout mice (lanes 9 to 11), but that THP knockout
without EG/D3 treatment did not induce OPN expression (lanes 6 to
8). Also note that EG/D3 treatment failed to induce THP in wild-type
mice (lanes 3 to 5). (B) Total kidney proteins were resolved by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and
immunoblotted with an anti-OPN antibody followed by an antibody
against mitogen activated protein kinase (MAPK), which was used to
normalize protein loading. Note that EG/D3 treatment triggers a slight
increase of OPN protein in wild-type mice and a marked increase of
OPN in THP knockout mice.
mice [16]. Thus, it appears that both OPN and THP are
required to maintain a healthy kidney.
The precise mechanism by which THP and OPN ex-
ert their inhibitory effects on calcium crystal formation
is under intensive investigation, but it appears that direct
binding between these macromolecules and calcium ions
or calcium crystals may be crucial. Both proteins con-
tain calcium-binding motifs, with OPN having one and
THP having two in its epidermal growth factor (EGF)-
like repeats [12] [Mo and Wu, unpublished observations,
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Fig. 5. Immunolocalization of osteopontin (OPN) in wild-type (A to C) and knockout (D to F) mouse kidneys. Sections of wild-type and THP
knockout mouse kidneys were immunohistochemically stained with an anti-OPN antibody. Note that while OPN expression is normally at low
levels and is restricted to thick-ascending limb of Henle’s loop (A), outer medulla (B), and papillary epithelium (C), its expression is dramatically
induced in almost all tubular epithelial cells in THP knockout mice pretreated with ethylene glycol (EG)/vitamin D3 (D3) (D to F), as well as in
the epithelium of Bowman’s capsule (magnifications are 200× for all panels).
2004]. Alternatively, THP and OPN could bind to cal-
cium via their abundant negatively charged groups.
THP is heavily sialylated, whereas OPN is both sialy-
lated and highly phosphorylated at its clusters of serine
and threonine residues [26, 27]. There may be multiple
consequences from the binding of these macromolecules
to calcium, such as (1) reducing the intratubular calcium
concentration to below the threshold of crystallization;
(2) inhibiting calcium crystal aggregation and growth; and
(3) blocking crystals from adhering to the renal epithe-
lial cells, a critical step in stone retention [5]. It has been
established that THP is a GPI-linked surface protein cov-
ering the luminal membrane of the thick ascending limb
of Henle’s loop [19]. While OPN is a secretory protein, it
is also found on the membrane surface, particularly that
of the renal papillary epithelium, presumably through the
interaction of OPN’s arginine-glycline-aspartate (RGD)
sequence with surface membrane receptors (Fig. 5) [9,
13]. It is conceivable, therefore, that both proteins may
act in certain ways to prevent crystal-epithelial interac-
tion. Alternatively, the crystal inhibitory activity of OPN
and THP may be indirect. It is known that ethylene glycol,
which has been widely used to induce renal stone forma-
tion in rats, causes renal tubular cell injury [28]. It cannot
be ruled out, therefore, that THP is involved in mod-
ulating renal cell damage, necrosis and apoptosis, thus
indirectly preventing calcium crystal formation. Regard-
less of whether the role of THP is direct or indirect, the
fact that ethylene glycol and vitamin D3 treatment causes
severe calcium crystal formation in THP knockout mice,
but none in wild-type mice, unequivocally demonstrates
THP as a potent inhibitor of calcium crystal formation.
Naturally occurring mutations of the THP gene have
recently been linked to familial juvenile hyperuricemic
nephropathy and medullary cystic kidney disease 2 [29].
It has been shown that the mutations lead to misfolding
and faulty delivery of THP to the luminal surface, result-
ing in lower-than-normal urinary THP level [30, 31]. Of
note, renal stone diseases have not been described as a
common feature, at least in the reported patient fami-
lies [32]. It is possible that the limited number of patients
do not have other stone-forming risk factors. It is also
possible that gene ablation and gene mutations can have
different biologic consequences on renal physiology, thus
presenting different phenotypes. Further investigation is
needed to clarify these issues.
Renal stone disease and urinary tract infection are both
exceedingly common conditions in humans. More than
10% of the United States population will suffer from a
kidney stone during their lifetime. Approximately 1 mil-
lion cases of renal stones were diagnosed in 1996 and the
incidence has been rising in recent years due to as yet un-
known reasons [33]. Urinary tract infection is the second
most common infectious disease in developed countries,
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afflicting 150 million people annually on a global basis
[34]. Both diseases occur in otherwise healthy individuals
and are frequently recurrent, raising the possibility that
deficiency in innate defenses of the urinary tract plays
critical roles in an individual’s susceptibility to these dis-
ease conditions. By ablating the murine THP gene, we
have provided the first in vivo evidence clearly establish-
ing that THP is on the first line of host defenses against
both renal stone formation and bacterial infection [24].
These results from mice may also reflect conditions in
humans because quantitative and qualitative defects of
THP have been frequently observed in human diseases.
For instance, reduced urinary excretion of THP has been
associated with recurrent kidney stone formers in sev-
eral cohorts [35, 36]. In addition, insufficient sialylation
of THP has been shown to cause a functional defect in
the inhibition of stone formation in vitro [37, 38]. THP
abnormalities have also been found in type I diabetics,
who frequently have either a profound reduction in uri-
nary THP or an altered THP glycosylation pattern [39,
40]. Since diabetics are prone to developing urinary tract
infections, it would be interesting to determine whether
a THP defect contributes to their propensity for urinary
tract infections. The majority of recurrent urinary tract
infections occur in anatomically normal individuals. Our
studies draw attention to the possibility that physiologic
defects in the THP component of innate urinary tract
defenses may contribute to the predisposition of some
individuals to recurrent urinary tract infections. Finally,
it is known that recurrent urinary tract infections are as-
sociated with an increased risk of renal stone formation
[41]. Our findings raise the possibility that a THP defect
provides a common link between these two seemingly
unrelated diseases.
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